| Dr Linda Mavil Ferrer, MD | |
|
816 22nd Ave, Suite 100, Kearney, NE 68845 | |
| (308) 865-2263 | |
| (308) 865-2541 |
| Full Name | Dr Linda Mavil Ferrer |
|---|---|
| Gender | Female |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 21 Years |
| Location | 816 22nd Ave, Kearney, Nebraska |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295113439 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 33269 (Nebraska) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Kearney Regional Medical Center | Kearney, NE | Hospital |
| Tri Valley Health System | Cambridge, NE | Hospital |
| Gothenburg Memorial Hospital | Gothenburg, NE | Hospital |
| Chi Health Good Samaritan | Kearney, NE | Hospital |
| Lexington Regional Health Center | Lexington, NE | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Bryan Hospital Kearney | 5991195547 | 91 |
| Bryan Hospital Kearney | 5991195547 | 91 |
News Archive
Researchers already know that alcohol dependence is strongly associated with impaired impulse control or, more precisely, the inability to choose large, delayed rewards rather than smaller but more immediate rewards.
BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that it has been awarded a $77.2 million contract modification by the U.S. Department of Health & Human Services (HHS) to complete Phase 3 development of its influenza neuraminidase inhibitor, intravenous (i.v.) peramivir, for the treatment of complicated influenza.
For women undergoing breast cancer surgery, a technique called lipofilling—using the patient's own fat cells to optimize the results of breast reconstruction—does not increase the risk of recurrent breast cancer, reports a study in the February issue of Plastic and Reconstructive Surgery, the official medical journal of the American Society of Plastic Surgeons.
Cancer cells are a problem for the body because they multiply recklessly, refuse to die and blithely metastasize to set up shop in places where they don't belong. One protein that keeps healthy cells from behaving this way is a tumor suppressor named p53. This protein stops potentially precancerous cells from dividing and induces suicide in those that are damaged beyond repair. Not surprisingly, p53's critical function is disrupted in most cancers.
Intermedix Corporation, a leading provider of revenue cycle management and software solutions to the emergency healthcare industry, today announced the completion of its previously announced acquisition by Thomas H. Lee Partners, L.P. from Parthenon Capital Partners and its minority shareholders including Glenview Capital Management.
› Verified 1 days ago
| Entity Name | Kearney Regional Medical Center Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174932388 PECOS PAC ID: 7517109408 Enrollment ID: O20141029001548 |
News Archive
Researchers already know that alcohol dependence is strongly associated with impaired impulse control or, more precisely, the inability to choose large, delayed rewards rather than smaller but more immediate rewards.
BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that it has been awarded a $77.2 million contract modification by the U.S. Department of Health & Human Services (HHS) to complete Phase 3 development of its influenza neuraminidase inhibitor, intravenous (i.v.) peramivir, for the treatment of complicated influenza.
For women undergoing breast cancer surgery, a technique called lipofilling—using the patient's own fat cells to optimize the results of breast reconstruction—does not increase the risk of recurrent breast cancer, reports a study in the February issue of Plastic and Reconstructive Surgery, the official medical journal of the American Society of Plastic Surgeons.
Cancer cells are a problem for the body because they multiply recklessly, refuse to die and blithely metastasize to set up shop in places where they don't belong. One protein that keeps healthy cells from behaving this way is a tumor suppressor named p53. This protein stops potentially precancerous cells from dividing and induces suicide in those that are damaged beyond repair. Not surprisingly, p53's critical function is disrupted in most cancers.
Intermedix Corporation, a leading provider of revenue cycle management and software solutions to the emergency healthcare industry, today announced the completion of its previously announced acquisition by Thomas H. Lee Partners, L.P. from Parthenon Capital Partners and its minority shareholders including Glenview Capital Management.
› Verified 1 days ago
| Entity Name | Bryan Hospital Kearney |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033875380 PECOS PAC ID: 5991195547 Enrollment ID: O20211214002678 |
News Archive
Researchers already know that alcohol dependence is strongly associated with impaired impulse control or, more precisely, the inability to choose large, delayed rewards rather than smaller but more immediate rewards.
BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that it has been awarded a $77.2 million contract modification by the U.S. Department of Health & Human Services (HHS) to complete Phase 3 development of its influenza neuraminidase inhibitor, intravenous (i.v.) peramivir, for the treatment of complicated influenza.
For women undergoing breast cancer surgery, a technique called lipofilling—using the patient's own fat cells to optimize the results of breast reconstruction—does not increase the risk of recurrent breast cancer, reports a study in the February issue of Plastic and Reconstructive Surgery, the official medical journal of the American Society of Plastic Surgeons.
Cancer cells are a problem for the body because they multiply recklessly, refuse to die and blithely metastasize to set up shop in places where they don't belong. One protein that keeps healthy cells from behaving this way is a tumor suppressor named p53. This protein stops potentially precancerous cells from dividing and induces suicide in those that are damaged beyond repair. Not surprisingly, p53's critical function is disrupted in most cancers.
Intermedix Corporation, a leading provider of revenue cycle management and software solutions to the emergency healthcare industry, today announced the completion of its previously announced acquisition by Thomas H. Lee Partners, L.P. from Parthenon Capital Partners and its minority shareholders including Glenview Capital Management.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Linda Mavil Ferrer, MD 816 22nd Ave, Suite 100, Kearney, NE 68845-2206 Ph: (308) 865-2263 | Dr Linda Mavil Ferrer, MD 816 22nd Ave, Suite 100, Kearney, NE 68845 Ph: (308) 865-2263 |
News Archive
Researchers already know that alcohol dependence is strongly associated with impaired impulse control or, more precisely, the inability to choose large, delayed rewards rather than smaller but more immediate rewards.
BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that it has been awarded a $77.2 million contract modification by the U.S. Department of Health & Human Services (HHS) to complete Phase 3 development of its influenza neuraminidase inhibitor, intravenous (i.v.) peramivir, for the treatment of complicated influenza.
For women undergoing breast cancer surgery, a technique called lipofilling—using the patient's own fat cells to optimize the results of breast reconstruction—does not increase the risk of recurrent breast cancer, reports a study in the February issue of Plastic and Reconstructive Surgery, the official medical journal of the American Society of Plastic Surgeons.
Cancer cells are a problem for the body because they multiply recklessly, refuse to die and blithely metastasize to set up shop in places where they don't belong. One protein that keeps healthy cells from behaving this way is a tumor suppressor named p53. This protein stops potentially precancerous cells from dividing and induces suicide in those that are damaged beyond repair. Not surprisingly, p53's critical function is disrupted in most cancers.
Intermedix Corporation, a leading provider of revenue cycle management and software solutions to the emergency healthcare industry, today announced the completion of its previously announced acquisition by Thomas H. Lee Partners, L.P. from Parthenon Capital Partners and its minority shareholders including Glenview Capital Management.
› Verified 1 days ago
Ronald Dobesh, M.D. Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 3219 Central Ave, Kearney, NE 68847 Phone: 308-865-2808 | |
Dr. John S Waters, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 10 E 31st St, Kearney, NE 68847 Phone: 308-865-7100 | |
Dr. Panayotis-alain Efstratiou, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 3219 Central Ave Ste 201, Kearney, NE 68847 Phone: 308-865-7271 | |
Dr. Meenakshi Ghosh, Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 3219 Central Ave Ste 200, Kearney, NE 68847 Phone: 308-865-2370 | |
Lissa Woodruff, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 3219 Central Ave, Kearney, NE 68847 Phone: 308-865-2808 | |
Dr. Anub George John, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 3219 Central Ave, Kearney, NE 68847 Phone: 308-865-7271 Fax: 308-865-2045 | |
Scott Smith, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 816 22nd Ave, Suite 100, Kearney, NE 68845 Phone: 308-865-2263 Fax: 308-865-2541 |